Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

611 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Modulation of tumor eIF4E by antisense inhibition: A phase I/II translational clinical trial of ISIS 183750-an antisense oligonucleotide against eIF4E-in combination with irinotecan in solid tumors and irinotecan-refractory colorectal cancer.
Duffy AG, Makarova-Rusher OV, Ulahannan SV, Rahma OE, Fioravanti S, Walker M, Abdullah S, Raffeld M, Anderson V, Abi-Jaoudeh N, Levy E, Wood BJ, Lee S, Tomita Y, Trepel JB, Steinberg SM, Revenko AS, MacLeod AR, Peer CJ, Figg WD, Greten TF. Duffy AG, et al. Among authors: wood bj. Int J Cancer. 2016 Oct 1;139(7):1648-57. doi: 10.1002/ijc.30199. Epub 2016 Jun 27. Int J Cancer. 2016. PMID: 27194579 Free PMC article. Clinical Trial.
Phase I study of hepatic arterial melphalan infusion and hepatic venous hemofiltration using percutaneously placed catheters in patients with unresectable hepatic malignancies.
Pingpank JF, Libutti SK, Chang R, Wood BJ, Neeman Z, Kam AW, Figg WD, Zhai S, Beresneva T, Seidel GD, Alexander HR. Pingpank JF, et al. Among authors: wood bj. J Clin Oncol. 2005 May 20;23(15):3465-74. doi: 10.1200/JCO.2005.00.927. J Clin Oncol. 2005. PMID: 15908655 Free PMC article. Clinical Trial.
Vandetanib, designed to inhibit VEGFR2 and EGFR signaling, had no clinical activity as monotherapy for recurrent ovarian cancer and no detectable modulation of VEGFR2.
Annunziata CM, Walker AJ, Minasian L, Yu M, Kotz H, Wood BJ, Calvo K, Choyke P, Kimm D, Steinberg SM, Kohn EC. Annunziata CM, et al. Among authors: wood bj. Clin Cancer Res. 2010 Jan 15;16(2):664-72. doi: 10.1158/1078-0432.CCR-09-2308. Epub 2010 Jan 12. Clin Cancer Res. 2010. PMID: 20068097 Free PMC article. Clinical Trial.
Navigation systems for ablation.
Wood BJ, Kruecker J, Abi-Jaoudeh N, Locklin JK, Levy E, Xu S, Solbiati L, Kapoor A, Amalou H, Venkatesan AM. Wood BJ, et al. J Vasc Interv Radiol. 2010 Aug;21(8 Suppl):S257-63. doi: 10.1016/j.jvir.2010.05.003. J Vasc Interv Radiol. 2010. PMID: 20656236 Free PMC article. Review.
Liver resection and ablation for metastatic adrenocortical carcinoma.
Ripley RT, Kemp CD, Davis JL, Langan RC, Royal RE, Libutti SK, Steinberg SM, Wood BJ, Kammula US, Fojo T, Avital I. Ripley RT, et al. Among authors: wood bj. Ann Surg Oncol. 2011 Jul;18(7):1972-9. doi: 10.1245/s10434-011-1564-z. Epub 2011 Feb 8. Ann Surg Oncol. 2011. PMID: 21301973 Free PMC article.
A pilot feasibility study of TNFerade™ biologic with capecitabine and radiation therapy followed by surgical resection for the treatment of rectal cancer.
Citrin D, Camphausen K, Wood BJ, Quezado M, Denobile J, Pingpank JF, Royal RE, Alexander HR, Seidel G, Steinberg SM, Shuttack Y, Libutti SK. Citrin D, et al. Among authors: wood bj. Oncology. 2010;79(5-6):382-8. doi: 10.1159/000323488. Epub 2011 Mar 25. Oncology. 2010. PMID: 21447969 Free PMC article. Clinical Trial.
611 results